Heliyon · 2002 · 31 citations · 1 references
EducationMathematics EducationTeacher EducationClassroom AssessmentFormative AssessmentMathematics InstructionClassroom Assessment PracticesLesson ReflectionMathematics PedagogyReflective PracticeReflective WritingStudent ReflectionMathematical ThinkingReflective PedagogyReflective Practice ModelsReflective Teaching PracticeTeacher Reflective PracticeTeacher Self-reflectionTeaching Reflection
The current coronavirus disease 2019 (COVID-19) pandemic that is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a significant threat to public health. Although vaccines based on the mRNA of the SARS-CoV-2 spike protein have been developed to induce both cellular and humoral immunity against SARS-CoV-2, there have been some concerns raised about their high cost, particularly in developing countries. In the present study, we aim to identify an immunogenic peptide in the SARS-CoV-2 spike protein to activate cellular immunity, particularly CD4<sup>+</sup> helper T lymphocytes (Th cells), which are a commander of immune system. SARS-CoV-2 spike protein-derived peptides Spike<sub>448-477</sub> and Spike<sub>489-513(N501Y)</sub>-specific CD4<sup>+</sup> Th cell lines were generated by repetitive stimulation of healthy donor-derived CD4<sup>+</sup>T-cells with each peptide. Their HLA-restrictions were addressed by using blocking antibodies against HLA and HLA-transfected L-cells. The epitopes of Spike<sub>448-477</sub>-specific CD4<sup>+</sup> Th cell lines were defined using a series of 7-14-mer overlapping truncated peptides and alanine-substituted epitope peptides. To address responsiveness of these CD4<sup>+</sup> Th cell lines to several SARS-CoV-2 variants, we stimulated the CD4<sup>+</sup> Th cell lines with mutated peptides. We addressed whether these identified peptides were useful for monitoring T-cell-based immune responses in vaccinated donors using the IFN-γ ELISpot assay. The Spike<sub>448-477</sub> peptide was found to be a promiscuous peptide presented by HLA- DRB1*08:02, DR53, and DPB1*02:02. Although HLA-DPB1*02:02-restricted CD4<sup>+</sup> Th cells did not response to some peptides with the L452R and L452Q mutations, the other CD4<sup>+</sup> Th cells were not affected by any mutant peptides. We developed two tetramers to detect HLA-DRB1*08:02/Spike<sub>449-463</sub>- and Spike<sub>449-463</sub>(L452R/Y453F)-recognizing CD4<sup>+</sup> Th cells. Spike<sub>489-513(N501Y)</sub> peptide was also a promiscuously presented to HLA-DRB1*09:01 and DRB1*15:02. The T-cell responses specific to both peptides Spike<sub>448-477</sub> and Spike<sub>489-513</sub> were detected in PBMCs after vaccinations. In addition, we observed that the Spike<sub>448-477</sub> peptide activated both CD8<sup>+</sup> T-cells and CD4<sup>+</sup> Th cells in individuals receiving mRNA vaccines. SARS-CoV-2 spike protein-derived peptides, Spike<sub>448-477</sub> and Spike<sub>489-513</sub>, include several epitopes that are presented by multiple HLA-class II alleles to activate CD4<sup>+</sup> Th cells, which are considered useful for monitoring the establishment of acquired immunity after vaccination.
1
An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin.
Yoshihiko Hirohashi, Toshihiko Torigoe, Akiko Maeda et al. · PubMed · 2002 · 188 citations
Life Sciences, Immunology, Oncology +14